A Phase Ib Study Investigating the Combination of Everolimus With Trastuzumab and Vinorelbine in Patients With HER2-Overexpressing Metastatic Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2016
At a glance
- Drugs Everolimus (Primary) ; Trastuzumab; Vinorelbine
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Novartis
- 06 Oct 2011 Actual end date (1 Jun 2010) added as reported by ClinicalTrials.gov.
- 06 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.